Medicare Radiation Radiopharmaceuticals 
AuntMinnie
JULY 12, 2024
Reshaping the hospital's nuclear medicine and radiopharmaceutical strategy toward theranostics involves intensive and inclusive planning, Beyder explained at SNMMI. Centers for Medicare and Medicaid (CMS) and manufacturers that agree to provide pharmaceuticals at significantly reduced rates for facilities that qualify. The bottom line?
AuntMinnie
NOVEMBER 4, 2024
Centers for Medicare & Medicaid Services (CMS) 2025 Medicare Physician Fee Schedule (MPFS) and Hospital Outpatient Prospective Payment System (HOPPS) final rules. The American Society for Radiation Oncology (ASTRO) was disappointed in the final MPFS rule. Radiological societies have mixed views on the U.S.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
AuntMinnie
OCTOBER 2, 2024
Scientific Paper of the Year Advanced Practice Provider Procedures Commonly Performed in Interventional Radiology: Medicare Volume Trends From 2010 to 2021. Effects of low-dose ionizing radiation on genomic instability in interventional radiology workers. Radiologist Workforce Attrition from 2019 to 2024: A National Medicare Analysis.
Imaging Technology
MAY 23, 2023
milla1cf Tue, 05/23/2023 - 11:36 May 23, 2023 — More than 9 in 10 radiation oncologists report that their practices face clinical staff shortages , according to a new national survey from the American Society for Radiation Oncology ( ASTRO ). Radiation oncologists from across the country are in Washington, D.C.
AuntMinnie
JANUARY 11, 2024
The Centers for Medicare and Medicaid Services (CMS) has established a national payment rate for RefleXion Medical's Scintix biology-guided radiotherapy system. These are created by injecting the patient with a radiopharmaceutical to deliver a radiation dose that targets the cancer itself.
Imaging Technology
JULY 20, 2023
milla1cf Thu, 07/20/2023 - 20:11 July 20, 2023 — The members of the American Society for Radiation Oncology ( ASTRO ) recently elected three new officers to ASTRO’s Board of Directors, including Sameer Keole , MD, FASTRO , as President-elect; Wendy Woodward , MD, PhD, FASTRO, as Science Council Vice Chair; and Vivek S.
Imaging Technology
JANUARY 12, 2024
a therapeutic oncology company, announced that the Centers for Medicare and Medicaid Services (CMS) has established a national payment rate for RefleXion’s SCINTIX biology-guided radiotherapy using CMS’ New Technology (NT) Ambulatory Payment Classification (APC) pathway. 1, 2024, to describe SCINTIX therapy.
Expert insights. Personalized for you.
264 
Let's personalize your content